About This Research Study
While diet and exercise can help manage the symptoms of type 2 diabetes (T2D), there is no cure. People with T2D either resist the effects of insulin, or their bodies don’t produce enough of the hormone to maintain normal levels of glucose. Tekton Research is conducting a clinical trial for an investigational weight loss medication for individuals with type 2 diabetes. Qualified participants may be compensated up to $1,000 for time and travel.
Eligible participants…
- Must be 18 years or older
- Must be diagnosed with type 2 diabetes
- Must be on a stable dose of metformin with or without a sodium-glucose cotransporter-2 inhibitor (SGLT2i)
- Must not be taking any additional glucose-lowering drug
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.